Terms: = Leukemia AND CDK4, PSK-J3, 1019, ENSG00000135446, MGC14458, CMM3, P11802 AND Clinical Outcome
5 results:
1. Rebound lymphocytosis in a patient with chronic lymphocytic leukemia after cessation of a CDK 4/6 inhibitor for concomitant breast cancer.
Doucette K; Lai C; Pohlmann PR
Breast J; 2020 Oct; 26(10):2031-2033. PubMed ID: 32639043
[TBL] [Abstract] [Full Text] [Related]
2. [Allogeneic Hematopoietic Stem Cell Transplantation for Treatment of T Cell Lymphoblastic Lymphoma - clinical observation of 10 Cases].
Gong F; Chen H; Zhao LY; Wang T; Zhang R; Wu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Dec; 24(6):1759-1763. PubMed ID: 28024490
[TBL] [Abstract] [Full Text] [Related]
3. Methylation of INK4 and CIP/KIP families of cyclin-dependent kinase inhibitor in chronic lymphocytic leukaemia in Chinese patients.
Chim CS; Fung TK; Wong KF; Lau JS; Law M; Liang R
J Clin Pathol; 2006 Sep; 59(9):921-6. PubMed ID: 16565223
[TBL] [Abstract] [Full Text] [Related]
4. Frequent disruption of the RB1 pathway in diffuse large B cell lymphoma: prognostic significance of E2F-1 and p16INK4A.
Møller MB; Kania PW; Ino Y; Gerdes AM; Nielsen O; Louis DN; Skjødt K; Pedersen NT
Leukemia; 2000 May; 14(5):898-904. PubMed ID: 10803523
[TBL] [Abstract] [Full Text] [Related]
5. Homozygous deletion of the p16/MTS1 gene in pediatric acute lymphoblastic leukemia is associated with unfavorable clinical outcome.
Kees UR; Burton PR; Lü C; Baker DL
Blood; 1997 Jun; 89(11):4161-6. PubMed ID: 9166859
[TBL] [Abstract] [Full Text] [Related]
